IMAC Holdings Reports $2.2M Net Loss in Q1 2025 Amid Rising Operational Challenges

IMAC Holdings, Inc. (NASDAQ: IMAC) has released its financial results for the three months ended March 31, 2025. The company, which operates primarily in precision medicine for oncology treatment, faces significant challenges reflected in its income statement.

Key Financial Highlights:

• Revenues: $1,500 for Q1 2025, compared to $0 for Q1 2024.
• Gross Loss: $(101,687) in Q1 2025.
• Total Operating Expenses: $2,087,214 in Q1 2025, significantly higher than $408,630 in Q1 2024.
• Net Loss: $(2,199,868) for Q1 2025, up from a net loss of $(407,219) in Q1 2024.
• Net Loss Available to Common Stockholders: $(3,414,205) in Q1 2025, compared to $(616,584) in Q1 2024.
• Net Loss Per Share: $(1.08) for Q1 2025, compared to $0.35 for the same period in 2024.
• Cash Position: $30,880 as of March 31, 2025, down from $504,189 at the end of 2024.
• Current Liabilities: $8.8 million, up from $7.2 million at the end of the previous year.
• Accumulated Deficit: $(67,184,020) as of March 31, 2025.

Positive Aspects:

• The company reported its first revenue of $1,500, marking a potential turning point in operational activity.
• Successful conversion of preferred stock, which may alleviate some financial burden as they transition to a more equity-based structure.

Negative Aspects:

• The significant increase in operating expenses, driven by costs associated with general and administrative expenses, raises concerns about operational efficiency.
• The net loss has widened compared to Q1 2024, indicating financial distress and a continuing trend of losses which could threaten the company's going concern status.
• Current liabilities greatly exceed current assets indicating liquidity issues.
• Inflation has negatively impacted operational costs, particularly in staffing and supplies, contributing to financial strain.

Outlook:

IMAC Holdings is at a crucial juncture as it attempts to grow its laboratory capabilities and stabilize its financial health amid rising operational costs and mounting losses. Management highlights the necessity for additional capital to support operations, posing a risk of reducing or ceasing operations if funds cannot be secured. Maintaining a close watch on their ability to attract skilled personnel and raise financing will be crucial for turning around their current trajectory.